First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action

Title
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action
Authors
Keywords
EP217609, Healthy subjects, Dual thrombin and indirect Xa inhibition, First in man, Pharmacokinetics and pharmacodynamics
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 9, Pages 1041-1050
Publisher
Springer Nature
Online
2016-06-03
DOI
10.1007/s00228-016-2077-2

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now